Volume 13, Number 9—September 2007
Dispatch
Coronavirus Antibodies in African Bat Species
Table
ELISA: positive/tested (%)† |
WB: positive/ tested‡ | IIFT: positive/ tested‡ | |||||
---|---|---|---|---|---|---|---|
Limpopo Province, SA | Mpumalanga Province, SA | Oriental Province, DRC | Bandundu Province, DRC | Total | |||
Fruit bats | |||||||
Casinycteris argynnis | 0/3 | 0/3 | |||||
Eidolon helvum | 0/6 | 0/6 | |||||
Epomophorus gambianus | 0/4 | 0/6 | 0/10 | ||||
Epomophorus wahlbergi | 0/2 | 0/2 | |||||
Epomops franqueti | 0/5 | 0/5 | |||||
Hypsignathus monstrosus | 1/11 (9.1) | 1/11 (9.1) | 1/1 | 0/1 | |||
Lyssonycteris angolensis | 1/16 (6.3) | 0/2 | 1/18 (5.6) | 1/1 | 0/1 | ||
Myonycteris torquata | 1/7 (14.3) | 1/7 (14.3) | |||||
Rousettus aegyptiacus |
11/29 (37.9) |
17/142
(12.0) |
28/171
(16.4) |
26/26 |
7/26 |
||
Insect bats | |||||||
Chaerephon pumila | 0/35 | 0/18 | 0/1 | 0/54 | |||
Hipposideros caffer | 0/5 | 0/9 | 0/15 | ||||
Hipposideros commersoni | 0/16 | 0/16 | |||||
Miniopterus inflatus | 1/34 (2.9) | 1/34 (2.9) | |||||
Miniopterus schreibersi | 0/1 | 0/1 | |||||
Mops condylurus | 3/19 (15.8) | 11/96 (11.5) | 14/115 (12.2) | 8/9 | 5/9 | ||
Mops midas | 0/15 | 0/15 | |||||
Myotis bocagei | 0/1 | 0/1 | |||||
Nycteris argae | 0/1 | 0/1 | |||||
N. thebaica | 0/6 | 0/6 | |||||
Pipistrellus capensis | 0/1 | 0/1 | |||||
Rhinolophus darlingi | 0/1 | 0/1 | |||||
Rhinolophus landeri | 0/2 | 0/2 | |||||
Rhinolophus fumigatus | 1/204 (0.5) | 1/204 (0.5) | |||||
Scotophilus borbonicus | 0/1 | 0/1 | |||||
S. dinganii | 0/5 | 0/5 | |||||
Taphozous mauritianus |
0/1 |
0/1 |
|||||
Totals | 14/128 (10.9) | 11/120 (9.2) | 20/422 (4.7) | 2/35 (5.7) | 47/705 (6.7) | 36/37 | 12/37 |
*SARS-CoV, severe acute respiratory syndrome–associated coronavirus; SA, South Africa; DRC, Democratic Republic of Congo; WB, Western blot; IIFT, indirect immunofluorescence test.
†Serum specimens were screened for antibody by modification of a commercially available ELISA kit. Titers ranged from 1:50 to 1:800.
‡Confirmatory tests were performed by 2 WB analyses and IIFT when sufficient sample was available.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.